ETIOLOGY - PATHOGENESIS - IMMUNOLOGY
Celardo I et al
The immune system view of the coronavirus SARS-CoV-2
Biology Direct, December 2020; doi.org/10.1186/s13062-020-00283-2
Zhang L et al
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
MedRXiv, December 2020; doi: 10.1101/2020.12.12.422516
Huston NC et al
Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
Cell, July 2020; doi: 10.1016/j.molcel.2020.12.041
Chevrier S et al
A distinct innate immune signature marks progression from mild to severe COVID-19
Cell, August 2020; doi: 10.1016/j.xcrm.2020.100166
Delbo Larsen M et al
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Science December 2020; DOI: 10.1126/science.abc8378
Jarjour NN et al
T Cell Memory: Understanding COVID-19
Immunity, December 2020; doi: 10.1016/j.immuni.2020.12.009
De Candia P et al
T Cells: Warriors of SARS-CoV-2 Infection
Trends in Immunology, 13 November 2020 ; DOI:https://doi.org/10.1016/j.it.2020.11.002
Fajgenbaum DC et al
Cytokine Storm
NEJM, December 2020 ; DOI: 10.1056/NEJMra2026131
Luo J et al
The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2
Gene, November 2020; DOI: 10.1016/j.gene.2020.145325
Wabg K et al
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Signal Tranasduction Targeted Therapy, December 2020; doi.org/10.1038/s41392-020-00426-x
Poland G et al
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
The Lancet, November 2020; doi.org/10.1016/S0140-6736(20)32137-1
Ntoumi F et al
What if tropical diseases had as much attention as COVID?
Nature, November 2020 ; doi.org/10.1038/d41586-020-03220-5
Miller B
Science denial and COVID conspiracy theories potential neurological mechanisms and possible responses
JAMA, November 2020 ; doi:10.1001/jama.2020.21332
Lundstrom K et al
Viewpoint: Origin of SARS-CoV-2
Viruses, October 2020 ; doi.org/10.3390/v12111203
Plante JA et al
Spike mutation D614G alters SARS-CoV-2fitness
Nature, October 2020; DOI: 10.1038/s41586-020-2895-3
The Severe Covid-19 GWAS Group
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
New England JMedicine, October 2020; doi: 10.1056/NEJMoa2020283
Hypothesis to explain the severe form of COVID-19 in Northern Italy
Cegolon L et al
BMJ Global Health, June 2020; doi.org/10.1136/bmjgh-2020-002564
Arvin AM et al
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Nature, July 2020; doi.org/10.1038/s41586-020-2538-8
Natural selection versus creation: a review on the origin of SARS-COV-2
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Iba T. et al.
Coagulopathy of Coronavirus Disease 2019
Crit Care Med. May 2020; doi: 10.1097/CCM.0000000000004458
Zhu J et al
Viral dynamics of SARS-CoV-2 in saliva from infected patients
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.059
Zhang L et al
The D614G mutation in the SARS-CoV-2 spike protein reduces S1shedding and increases infectivity
BioRxiv, June 2020; doi.org/10.1101/2020.06.12.148726
Journal of Clinical Medicine, June 2020; doi: 10.3390/jcm9072038
Cheng Z.J. et al.
2019 Novel coronavirus : where we are and what we know
Infection, 2020; doi/org/101007/s15010-020-01401-y
Cassone A. et al.
Relationship between SARS-2-COV, ACE 2 and antihypertensives
Ahed of print
Moore J.B. et al
Cytokine release syndrome in severe COVID-19
Science, May 2020; doi: 10.1126/science.abb8925
Xiao K. et al.
Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins
Nature, 2020; doi.org/10.1038/s41586-020-2313-x
Ingraham N.E. et al.
Immunomodulation in COVID-19
Lancet Respiratory Medicine, 2020; doi.org/10.1016/S2213-2600(20)30226-5
Fauci A.S. et al
Covid-19 Navigating the uncharted
NEJM, February 2020; doi: 10.1056/NEJMe2002387
Editorial
Covid-19: too little, too late?
The Lancet, March 2020; vol 395
McCloskey B. et al.
SARS to novel coronavirus – old lessons and new lessons
Epidemiology and Infection, January 2020; doi.org/10.1017/S0950268820000254
Maier CL et al
COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
https://doi.org/10.1016/S0140-6736(20)31209-5
Yang R. et al.
Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China
JAMA Netw Open. 2020;3(5):e2010182. doi:10.1001/jamanetworkopen.2020.10182
Sward P. et al.
Age and sex differences in soluble ACE2 may give insights for COVID-19
Critical Care, May 2020; doi.org/10.1186/s13054-020-02942-2
Cassone A. et al.
A call to research: the relationship between SARS-2-CoV, ACE 2 and antihypertensives
Pathogens and Global Health, 2020; doi.org/10.1080/20477724.2020.1765650
Benvenuto D.
Evidence for mutations in SARS‐CoV‐2 Italian isolates potentially affecting virus transmission
Journal of Medical Virology, June 2020; doi.org/10.1002/jmv.26104
EPIDEMIOLOGY
Tan JY et al
COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations
Thorax, 22 December 2020; doi: 10.1136/thoraxjnl-2020-216637
Wibbens PD et al
Which COVID policies are most effective? A Bayesian analysis of COVID-19 by jurisdiction
PLoS One , 29 December 2020; doi.org/10.1371/journal.pone.0244177
Eunsun J et al
Understanding South Korea's Response to the COVID-19 Outbreak: A Real-Time Analysis
International Journal of Environmental Research, 21 December 2020; doi: 10.3390/ijerph17249571
Public Health England
Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01
re-designated as VOC 202012/01 on 18/12/2020.
COG – COVID-19 Genomic Consortium UK
Update on new SARS-CoV-2 variant and how COG-UK tracks emerging mutations
Wise J et al
Covid-19: New coronavirus variant is identified in UK
BMJ, 16 December 2020; DOI: 10.1136/bmj.m4857
Amendola A et al
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019
Emerging Infectious Diseases, 8 December 2020; DOI: 10.3201/eid2702.204632
Meyerowitz E et al
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
The Lancet, 7 december 2020; doi.org/10.1016/S1473-3099(20)30837-9
Larosa E et al
Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study
Euro Surveillance
Soltan AAS et al
Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test
The Lancet, 11 December 2020 ; doi.org/10.1016/S2589-7500(20)30274-0
Vos ERA et al
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
Journall of Epidemiology and Community Health, 28 November 2020; doi:10.1136/jech-2020-215678
Vogel G et al
Grade: incomplete
Science, 27 November 2020; DOI: 10.1126/science.370.6520.1023
Gudbjartsson DF et al
Humoral Immune Response to SARS-CoV-2 in Iceland
NEJM, 29 October 2020; DOI: 10.1056/NEJMoa2026116
Aydillo t ET AL
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Nejm, 1 December 2020; doi: 10.1056/NEJMc2031670
Stefanelli P et al
Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study
Clinical Microbiology and Infection, 27 November 2020; /doi.org/10.1016/j.cmi.2020.11.013
Armitage R et al
Antibiotic prescribing in general practice during COVID-19
The Lancet, 1 December 2020; doi.org/10.1016/S1473-3099(20)30917-8
The CDC
Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing
The CDC
Domestic Travel During the COVID-19 Pandemic
Waissberg D et al
Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office
BMC, 7 December 2020; DOI:10.21203/rs.3.rs-73054/v1
Chirizzi D et al
A Cluster-Randomized Trial ofHydroxychloroquine for Prevention of Covid-19
NEJM, 24 November 2020; DOI: 10.1056/NEJMoa2021801
Chirizzi D et al
SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy
EnvironmentInternational, 12 November 2020; doi.org/10.1016/j.envint.2020.106255
Cheng W et al
Successful interruption of seasonal influenza transmission under the COVID-19 rapid response in Zhejiang Province, China
Public Health, 20 October 2020; doi.org/10.1016/j.puhe.2020.10.011
Omer SB et al
Herd Immunity and Implications for SARS-CoV-2 Control
JAMA, 24 November 2020; DOI: 10.1001/jama.2020.20892
Spellberg B et al
Antibodies, Immunity, and COVID-19
JAMA, 24 November 2020; doi:10.1001/jamainternmed.2020.7986
Letizia AG et al
SARS-CoV-2 transmission among marine recruits during quarantine
NEJM, 11 November 2020; DOI: 10.1056/NEJMoa2029717
Liotti FM et al
Assessment of SARS-CoV-2 RNA test results among patients who recovered from COVID-19 with prior negative results
JAMA, 12 November 2020 ; doi:10.1001/jamainternmed.2020.7570
Lum BX et al
Establishing a new normal for hospital care: a whole of hospital approach to COVID-19
ClinicalInfectiousDiseases, 12 November 2020 ; doi.org/10.1093/cid/ciaa1722
Li Y et al
The temporal association of introducing and liftingnon-pharmaceutical interventions with the time-varyingreproduction number (R) of SARS-CoV-2: a modelling studyacross 131 countries
The Lancet, October 22, 2020 ; doi.org/10.1016/S1473-3099(20)30785-4
Basile K et al
Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19
ClinicalInfectiousDiseases, October 2020 ; doi: 10.1093/cid/ciaa1579
Zhao J et al
The Potential Intermediate Hosts for SARS-CoV-2
Frontiers in Microbiology, September 2020; doi: 10.3389/fmicb.2020.580137
Fang FC et al
COVID-19 - Lessons Learned and Questions Remaining
Clinical Infectious Diseases, October 2020; doi.org/10.1093/cid/ciaa1654
Juan Y et al
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
Nature Communications, October 2020; doi.org/10.1038/s41467-020-19238-2
Petersen I et al
Three Quarters of People with SARS-CoV-2 Infection are Asymptomatic: Analysis of English Household Survey Data
ClinicalEpidemiology, October 2020 ; doi.org/10.2147/CLEP.S276825
Prieto-Alhambra D et al
Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain
International Journal of Epidemiology, October 2020; doi.org/10.1093/ije/dyaa190
Liu Z et al
Dynamic emergency department response to the evolving COVID-19 pandemic: the experience of a tertiary hospital in Singapore
The Journal of the American College of Emergency Physicians, 25 September 2020; doi.org/10.1002/emp2.12264
Tillet RL et al
Genomic evidence for reinfection with SARS-CoV-2: a case study
The Lancet, 12 October 2020; DOI:doi.org/10.1016/S1473-3099(20)30764-7
Alwan NA et al
Scientific consensus on the COVID-19 pandemic: we need to act now
The Lancet, 15 October 2020; doi.org/10.1016/S0140-6736(20)32153-X
Walsh KA et al
The duration of infectiousness of individuals infected with SARS-CoV-2
Journal of Infection, 09 October 2020; doi.org/10.1016/j.jinf.2020.10.009
Sax P.E.
Does Remdesivir Actually Work?
HIV and ID Observations -NEJM Journal Watch, October 2020;
COVID-19: the worst may be yet to come
Editorial, July 2020.
Signorelli C et al
COVID-19 mortality rate in nine high-income metropolitan regions
Acta Biomed, 20 Jul 2020; doi: 10.23750/abm.v91i9-S.10134.
Petersen E et al
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Lancet infectious diseases, July 2020 ; doi.org/10.1016/S1473-3099(20)30484-9
Percivalle E. et al.
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
Eurosurveillance, June 2020; doi: 10.2807/1560-7917.ES.2020.25.24.2001031
Jamaludin S. et al .
COVID-19 exit strategy: Transitioning towards a new normal
Annals of Medicine and Surgery, November 2020; doi.org/10.1016/j.amsu.2020.09.046
Calcagno A. et al.
Risk of SARS-CoV-2 infection in healthcare workers, Turin, Italy
Emerging Infectious Diseases, October 2020; doi: 10.3201/eid2701.203027
Peeples L. et al.
Face masks: what the data say
Nature, October 2020 ;doi: 10.1038/d41586-020-02801-8
Sax P. E.
Does the White House Outbreak Invalidate the Strategy of Frequent Testing for COVID-19 Control?
NEJM – HIV and I.D.Journal watch, October 2020
Ortosecco G. et al.
First 70 Days Critical Data Trend for COVID-19 in Four Regions of Northern Italy: A Pilot Study.
Journal of Epidemiology and Global Health, September 2020; doi: 10.2991/jegh.k.200901.001
Tsai A et al
COVID-19 transmission in the U.S. before vs. after relaxation of statewide social distancing measures
Clinical Infecitous Diseases, October 2020 ;doi: 10.1093/cid/ciaa1502.
Flannery B et al
Systematic testing for influenza and COVID-19 among patients with respiratory illness
CID, 20 July 2020; doi.org/10.1093/cid/ciaa1023
Gupta V. et al.
Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1451
Mondelli M.U. et al.
Low risk of SARS-CoV-2 transmission by fomites in real-life conditions
The Lancet, September 29, 2020; doi.org/10.1016/S1473-3099(20)30678-2
Nacoti M. et al.
At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy: Changing Perspectives on Preparation and Mitigation
NEJM Catalyst, March 2020; doi: 10.1056/CAT.20.0080
Patel Shailesh Kumar P.S. et al.
Possibility of SARS-CoV-2 transmission from the breast milk of COVID-19 affected women patients to their infants: worries and strategies to counter it
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Caglayan Merve A. et al.
Out-patient management of patients with COVID-19 on home isolation
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Fusaroli P. et al.
On the death of 100+Italian doctors from COVID‑19
Infection, April 2020; doi.org/10.1007/s15010-020-01436-1
SzeS. et al.
The need for improved discharge criteria for hospitalised patients with COVID-19-implications for patients in long term care facilities
Age and Ageing, September 2020; doi.org/10.1093/ageing/afaa206
D’Arminio Monforte A. et al.
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease
International J Infectious Diseases, September 2020; doi.org.10.1016/j.ijid.2020.09.037
Servick K.
How will COVID-19 affect the coming flu season? Scientists struggle for clues
ScienceMag.org, August 2020; doi:10.1126/science.abe3374
Zhang S. et al.
Improved night shift schedule related to the mortality of critically ill patients with Corona Virus Disease 2019Sleep
Medicine, November 2020; doi.org/10.1016/j.sleep.2020.08.010
S.H. Ra et al.
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection
THORAX, September 2020; 10.1136/thoraxjnl-2020-215042
Buitrago-Garcia D. et al.
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
Plos Medicine, September 2020; doi.org/10.1371/journal.pmed.1003346
The COVID-19 Pandemic and the JAMA Network
JAMA, September 2020; doi:10.1001/jama.2020.18298
Brett T.S. et al.
Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies
PNAS.org, September 2020; doi.org/10.1073/pnas.2008087117
Boehmer T.K. et al.
Changing Age Distribution of the COVID-19 Pandemic — United States, May–August 2020
MMWR Morb Mortal Wkly Rep, September 2020; doi: 10.15585/mmwr.mm6939e1
Fuling Z. et al.
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey
Eclinical Medicine – The Lancet; September 2020;
Dookie N. et al.
Tuberculosis Elimination in the Era of COVID-19: A Moving Target
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1400
Larremore D.B. et al.
Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
MedRxiv, September 2020; doi: 10.1101/2020.06.22.20136309
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly
The Lancet COVID-19 Commissioners, Task Force Chairs, and Commission Secretariat
September 2020; doi.org/10.1016/ S0140-6736(20)31927-9
Meyerowitz E.A. et al.
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
Annals of Internal Medicine, September 2020; doi.org/10.7326/M20-5008
Khanh N.C. et al.
Transmission of severe acute respiratory syndrome Coronavirus 2 during long flight
Emerg. Infect. Dis., September 2020;
Luo K. Et al.
Transmission of SARS-CoV-2 in public transportation vehicles: a case study in Hunan Province, China
Open Forum Infectious Diseases, September 2020; doi.org/10.1093/ofid/ofaa430
Poon K.S. et al.
Caveats of reporting cycles threshold from SARS-CoV-2 qualitative PCR assays: a molecular diagnostic laboratory perspective
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1399
Muscatello D.J. et al.
Comparing mortalities of the first wave of coronavirus disease 2019 (COVID-19) and of the 1918–19 winter pandemic influenza wave in the USA
International Journal of Epidemiology, September 2020; doi.org/10.1093/ije/dyaa186
Mbow M. et al.
COVID-19 in Africa: Dampening the storm?
Science , August 2020; doi: 10.1126/science.abd3902
Ettman C.K. et al.
Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic
JAMA Netw Open. September 2020; e2019686
Martín-Rodríguez F. et al.
Predicting Health Care Workers' Tolerance of Personal Protective Equipment: An Observational Simulation Study
Clin. Simul. in Nursing, September 2020; doi.org/10.1016/j.ecns.2020.07.005
Rhee C. et al.
Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center
JAMA Netw., September 2020; doi:10.1001/jamanetworkopen.2020.20498
Guilamo-Ramos V. et al.
Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1348
Jonathan W. Cunningham J.W. et al.
Clinical Outcomes in Young US Adults Hospitalized With COVID-19
JAMA Intern Med., September 2020; doi:10.1001/jamainternmed.2020.5313
Atalla E. et al.
Readmissions among Patients with COVID‐19
Int. J Clin. Practice, September 2020; doi.org/10.1111/ijcp.13700
Worobey M. et al.
The emergence of SARS-CoV-2 in Europe and North America
Science , September 2020; doi 10.1126/science.abc8169
Kilaru A.S. et al.
Return Hospital Admissions Among 1419 Covid‐19 Patients Discharged from Five US Emergency Departments
Academic Emergency Medicine, August 2020; doi.org/10.1111/acem.14117
Flannery B. et al.
Systematic testing for influenza and COVID-19 among patients with respiratory illness
Clinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa1023
Serrano-Villar S. et al.
Lancet HIV, August 2020; doi: 10.1016/S2352-3018(20)30202-2
Bénézit F et al.
Infection, August 2020; doi: 10.1007/s15010-019-01388-1
Dzien A. et al.
Will the COVID-19 pandemic slow down in the Northern hemisphere by the onset of summer? An epidemiological hypothesis
Infection, August 2020; doi: 10.1007/s15010-020-01460-1
Rubin D. et al.
JAMA, July 2020; doi: 10.1001/jamanetworkopen.2020.16099
Almario C.V. et al.
Am J Gastroenterol., August 2020; doi: 10.14309/ajg.0000000000000798
Fauci A, Inserro A.
Am J Manag Care, July 2020; doi: 10.37765/ajmc.2020.43637
Clifford H.L. et al.
Research in the Context of a Pandemic
NEJM, July 2020; doi: 10.1056/NEJMe2024638
Logunov D.Y et al.
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
The Lancet, September 2020; doi.org/10.1016/ S0140-6736(20)31866-3
Keech C. et al.
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
NEJM, September 2020; doi : 10.1056/NEJMoa2026920
Burke R. M. et al.
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States
PloS One, September 2020 ; doi.org/10.1371/journal.pone.0238342
Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater Houston, Texas, Area
JAMA Network Open, July 2020; doi:10.1001/jamanetworkopen.2020.16451
Karagiannidis C. et al
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Lancet Respiratory Medicine, July 2020; doi: https://doi.org/10.1016/S2213-2600(20)30316-7
Chatzidimitriou M. et al
Repeated negative serological testing in otherwise healthy patients with COVID-19
Journal of Infectious Diseases, July 2020; doi.org/10.1093/infdis/jiaa453
Kogan N.E. et al
An Early Warning Approach to Monitor COVID-19 Activity with Multiple Digital Traces in Near Real-Time
ArXiv.org, July 2020 ; arXiv:2007.00756
Hoxha A. et al
Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
Lancet Infectious Diseases, July 2020 ; doi: 10.1016/S1473-3099(20)30560-0
Pollàn M. et al
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
The Lancet, July 2020; doi.org/10.1016/ S0140-6736(20)31483-5
Saloner B. et al
COVID-19 Cases and Deaths in Federal and State Prisons
JAMA, July 2020; doi:10.1001/jama.2020.12528
Torres J.P. et al
SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study
Clinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa955
Almario C.V. et al
Increased Risk of COVID-19 among users of Proton Pump Inhibitors
American Journal of Gastroenterology, July 2020;
Flannery B. et al
Systematic testing for influenza and COVID-19 among patients with respiratory illness
CLinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa1023
McCulloch D.J. et al
Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection
JAMA Network Open, July 2020; doi: 10.1001/jamanetworkopen.2020.16382
Havers F.P. et al
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
JAMA Internal Medicine, July, 2020; doi:10.1001/jamainternmed.2020.4130
Turriziani O. et al.
SARS‐CoV‐2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period
Journal of Medical Virology, July 2020; doi.org/10.1002/jmv.26332
Rubin D. et al.
Association of Social Distancing, Population Density, and Temperature With the Instantaneous Reproduction Number of SARS-CoV-2 in Counties Across the United States
JAMA Network Open, July 2020; doi:10.1001/jamanetworkopen.2020.16099
Rosselli D. et al.
Could SARS-CoV-2/COVID-19 simply fade away?
Le Infezioni in Medicina, Suppl. 1, 2020; 1-3
Bielecki M et al
Social distancing alters the clinical course of COVID-19 in young adults: A comparative cohort study
Clinical Infectious Diseases, June 2020; doi.org/10.1093/cid/ciaa889
Brown C et al
Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England
Journal of Infection, June 2020; doi.org/10.1016/j.jinf.2020.06.069
Pinninti S et al
Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2
Clinical Infectious Diseases, June 2020; doi.org/10.1093/cid/ciaa882
Lavezzo E et al
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
Nature, June 2020; doi.org/10.1038/s41586-020-2488-1
Weinberger DM et al
Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020
JAMA Internal Medicine, July 2020; doi:10.1001/jamainternmed.2020.3391
Nagler AR et al
Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City
Clinical Infectious Diseases, June 2020; doi.org/10.1093/cid/ciaa867
Torti C. et al.
Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
BMC Infectious Diseases, June 2020; doi.org/10.1186/s12879-020-05147-8
Bird P. et al.
High SARS-CoV-2 infection rates in respiratory staff nurses and correlation of COVID-19 symptom patterns with PCR positivity and relative viral loads
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.035
Rickman H.M. et al.
Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital
Clinical Infectious Diseases, June 2020 ; doi.org/10.1093/cid/ciaa816
Lombardi A. et al.
Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy
Clinical Microbiology and Infection, June 2020; doi.org/10.1016/j.cmi.2020.06.013
Lopez L. et al.
The end of social confinement and COVID-19 re-emergence risk
Nature Human Behaviour, June 2020; doi.org/10.1038/s41562-020-0908-8
Barnett M.L. et al.
Mortality, admissions, and patient census at SNFs in 3 US cities during the COVID-19 pandemic
JAMA, June 2020 ; doi:10.1001/jama.2020.11642
Souse G.J.B. et al.
Mortality and survival of COVID-19
Epidemiology and Infection, June 2020; doi.org/10.1017/S0950268820001405
Erikstrup C. et al.
Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors
MedRxiv, April 2020; doi.org/10.1101/2020.04.24.20075291
Robilotti E.V. et al.
Determinants of COVID-19 disease severity in patients with cancer
Nature Medicine, June 2020; doi.org/10.1038/s41591-020-0979-0
Paules C.I. et al.
JAMA, January 2020; doi: 10.1001/jama.2020.0757
Hunter P.
EMBO Rep., April 2020; doi: 10.15252/embr.202050334
Flaxman S. et al.
Estimating the number of infections and the impact of non-pharmaceutical interventions on covid 19
Imperial College, March 2020; doi.org/10.25561/77731
Cheng A.C. et al.
An outbreak of COVID-19 caused by a new coronavirus: what we know so far.
Med J Aust., March 2020; doi: 10.5694/mja2.50530
Paterlini M.
On the front lines of coronavirus: the Italian response to Covid-19
BMJ, March 2020; doi:10.1135/bmj.m1065
Rizzi M. et al.
Editorial Sars-Cov-2 invades the West. How to face a Covid-19 epidemic in Lombardy, Northern Italy?
Le infezioni in Medicina, 2020; n. 2, 133-134
Nishiura H. et al.
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
Int J of Inf Dis, February 2020; doi.org/10.1016/j.ijid.2020.03.020
Battegay M. et al.
2019-Novel coronavirus (2019-nCoV): estimanting the case fatality rate – a word of caution
Swiss Medical Weekly, February 2020; 150:w20203
Editorial
Humanity tested
Nature Biomedical Engineering April 2020; volume 4, pages 355–356
Kissler S.M. et al.
Science, April 2020 ; doi: 10.1126/science.abb5793
Wang K.W., et al.
Epidemiology of 2019 novel coronavirus in Jiangsu Province, China, after wartime control measures: a population-level retrospective study
Science Direct, April 2020; doi.org/10.1016/j.tmaid.2020.101654
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team,
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020
Cereda D. et al.
The early phase of the COVID-19 outbreak in Lombardy, Italy
Pan A et al.
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
JAMA, April 2020; doi: 10.1001/jama.2020.6130
Streeck H. et al.
Infection fatality rate (IFR) of SARS-CoV-2 infection in a German community with a super-spreading event
MedRx, May 2020; doi.org/10.1101/2020.05.04.20090076
Giesecke J.
The invisible pandemic
The Lancet, May 2020; doi.org/10.1016/S0140-6736(20)31035-7
Lai S. et al.
Effect of non-pharmaceutical interventions to contain COVID-19 in China
Nature, May 2020; doi.org/10.1038/s41586-020-2293-x
Fagiuoli S. et al.
Adaptations and Lessons in the Province of Bergamo
The New England Journal of Medicine, May 2020; doi:10.1056/NEJMc2011599
Michelozzi P et al
Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020
Buonomo B. et al.
Modelling information-dependent social behaviors in response to lockdowns: the case of COVID-19 epidemic in Italy
MedRxiv.org, May 2020; doi: https://doi.org/10.1101/2020.05.20.20107573
Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa578
Samuel Faust J.S.
Assessment of Deaths From COVID-19 and From Seasonal Influenza
Jama Int Med, May 2020; doi:10.1001/jamainternmed.2020.2306
Bi Q. et al.
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
MedRxiv, May 2020; doi.org/10.1101/2020.03.03.20028423.t
Amitava B. et al.
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
Lancet, May 2020; doi.org/10.1016/S0140-6736(20)30854-0
Giordano G. et al.
Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
Nature Medicine, April 2020; doi.org/10.1038/s41591-020-0883-7
Deng X. et al.
Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
The Journal of Infectious Diseases, April 2020; doi.org/10.1093/infdis/jiaa161
Salje H.
Estimating the burden of SARS-CoV-2 in France
Science, June 2020; doi: 10.1126/science.abc3517
Fontanet A. et al.
Cluster of COVID-19 in northern France: A retrospective closed cohort study
MedRXivApril 2020; doi.org/10.1101/2020.04.18.20071134
Rodríguez-Morales A.J. et al.
Genomic Epidemiology and its importance in the study of the COVID-19 pandemic
Le Infezioni in Medicina, 2020; n. 2: 139-142
Le Infezioni in Medicina, 2020; n. 2: 139-142
Abdullahi I.N. et al.
Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19
Le Infezioni in Medicina, 2020; n. 2: 166-173
Le Infezioni in Medicina, 2020; n. 2: 166-173
Antonello R.M. et al.
Letters to the editor: The seXY side of COVID-19: what is behind female protection?
Le Infezioni in Medicina,2020; n. 2: 288-289
Le Infezioni in Medicina,2020; n. 2: 288-289
Prevalence of Asymptomatic SARS-CoV-2 Infection
Annals of Internal Medicine, June 2020; doi.org/10.7326/M20-3012
Biagi A. et al.
Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.
Journal of Medical Virology, June 2020; doi.org/10.1002/jmv.26147
Sajadi M.M. et al.
Temperature, humidity and latitude analysis to estimate potential spread and seasonality of Coronavirus Disease 2019
JAMA, June 2020; doi:10.1001/jamanetworkopen.2020.11834
Flaxman S et al
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Nature, June 2020; doi.org/10.1038/s41586-020-2405-7
TRANSMISSION
Madas BG et al
Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles
Scientific Reports, 31 December 2020; doi.org/10.1038/s41598-020-79985-6
Atyeo C et al
Compromised SARS-CoV-2-specific placental antibody transfer
Cell, December 2020; doi: 10.1016/j.cell.2020.12.027
Heinrich F et al
Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa
Emerging Infectious Diseases, December 2020; DOI: 10.3201/eid2701.203112
Aydillo T et al
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
NEJM, December 2020; DOI: 10.1056/NEJMc2031670
Olusola-Makinde O et al
Ticking bomb: Prolonged faecal shedding of novel coronavirus (2019-nCoV) and environmental implications
Environmental Pollution, December 2020; DOI: 10.1016/j.envpol.2020.115485
Nissen C et al
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
Scientific Reports, November 2020 ; doi.org/10.1038/s41598-020-76442-2
Li M et al
Identifying novel factors associated with COVID-19 transmission and fatalityusing the machine learning approach
Science of the Total Environment, October 2020; doi.org/10.1016/j.scitotenv.2020.142810
Comber L et al
Airborne transmission of SARS-CoV-2 via aerosols
Reviews in Medical Virology, October 2020; doi.org/10.1002/rmv.2184
Riddell S et al
The effect of temperature on persistence of SARS-CoV-2 on common surfaces
Virology Journal, 07 October 2020; doi.org/10.1186/s12985-020-01418-7
Klompas M et al
Airborne Transmission of SARS-CoV-2Theoretical Considerations and Available Evidence
JAMA, July 2020; doi:10.1001/jama.2020.12458
Vivanti AJ et al
Transplacental transmission of SARS-CoV-2 infection
Nature Communications, July 2020; doi.org/10.1038/s41467-020-17436-6
Fernandez-Raga M. et al.
SARS-CoV-2 viability under different meteorological conditions, surfaces, fluids and transmission between animals
Environmental Research, October 2020 ; doi.org/10.1016/j.envres.2020.110293
Haitao T. et al .
COVID-19 and sex differences: mechanisms and biomarkers
Mechanism and Biomarkers, August 2020 ; doi.org/10.1016/j.mayocp.2020.07.024
Prather K.A. et al.
Airborne transmission of SARS-CoV-2
Science, October 2020 ;doi: 10.1126/science.abf0521
Kampf G. et al.
Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2
Journal of Hospital Infection, September 2020; doi.org/10.1016/j.jhin.2020.09.022
Oliveira L.V.
Current evidence of SARS-CoV-2 vertical transmission: an integrative review
Rev. Assoc. Med. Bras. September 2020; vol.66 supl.2
Bartoletti M. et al.
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study
Clinical Microbiology and Infection, September 2020; doi.org/10.1016/j.cmi.2020.09.014
Setti L.
Potential role of particulate matter in the spreading of COVID-19 in Northern Italy: first observational study based on initial epidemic diffusion
BMJ Journal, September 2020; 10.1136/bmjopen-2020-039338
Aitken R.J.
COVID-19 and human spermatozoa - potential risks for infertility and sexual transmission
Andrology, July 2020
Lui Y. et al
Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant
MedRxiv.org, April 2020 ; doi.org/10.1101/2020.04.16.20067728
Miller S.L. et al
Transmission of SARS-CoV-2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event
MedRxiv.org, June 2020; doi.org/10.1101/2020.06.15.20132027
Goldman E. et al
Exaggerated risk of transmission of COVID-19 by fomites
Lancet Infectious Diseases, July 2020; doi: 10.1016/S1473-3099(20)30561-2
Li R. et al.
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
Science, May 2020; doi: 10.1126/science.abb3221
Letter to the Editor
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
NEJM, March 2020; doi: 10.1056/nejmc2004973
Lyon study group on Covid-19 infection
Fast nosocomial spread of SARS-CoV2 in a French geriatric unit
Infection Control & Hosp Epidem., April 2020; doi: 10.1017/ice.2020.99
Ferretti L. et al.
Science, March 2020 ; doi: 10.1126/science.abb6936
Goldstein E. et al.
Temporal rise in the proportion of younger adults and older adolescents among COVID-19 cases following the introduction of physical distancing measures, Germany, March to April 2020
Eurosurveillance, April 2020; doi.org/10.2807/1560-7917.ES.2020.25.17.2000596
Sehra S.T. et al.
Maximum Daily Temperature, Precipitation, Ultra-Violet Light and Rates of Transmission of SARS-Cov-2 in the United States
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa681
PREVENTION - PUBLIC HEALTH
Spaccaferri G et al
Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020.
Eurosurveillance, 17 December 2020; doi.org/10.2807/1560-7917.ES.2020.25.50.2001974
Brauner JM et al
Inferring the effectiveness of government interventions against COVID-19
Science, 15 December 2020; DOI: 10.1126/science.abd9338
Chirathaworn C et al
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020
PLoS One, October 2020; doi.org/10.1371/journal.pone.0236905
Jefferis S et al
COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study
The Lancet, 13 October 2020; doi.org/10.1016/S2468-2667(20)30225-5
Rice K et al
Effect of school closures on mortality from coronavirus disease 2019: old and new predictions
BMJ, 07 October 2020 ; doi.org/10.1136/bmj.m3588
Batisse D et al
Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
J Infect. 2020 Jun 30; doi: 10.1016/j.jinf.2020.06.073
Del Rio C et al
Long-term Health Consequences of COVID-19
JAMA, October 2020; doi:10.1001/jama.2020.19719
Lynch JB et al
Infectious diseases society of America guidelines on infection prevention for health care personnel caring for patients with suspected or Known COVID-19
CID, 2020 Jul 27; doi: 10.1093/cid/ciaa1063.
Bénézit F. et al.
Infection, August 2020; doi: 10.1007/s15010-019-01388-1
Mei Q. et al
Assessment of patients who tested positive for COVID-19 after recovery
Lancet Infectious Diseases, july 2020 ; doi: 10.1016/S1473-3099(20)30433-3
Carfì A. et al
Persistent Symptoms in Patients After Acute COVID-19
JAMA, july 2020 ; doi:10.1001/jama.2020.12603
Rokadiya S. et al
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital
Journal of Infection, July 2020; doi.org/10.1016/j.jinf.2020.07.007 0163-4453
Liu C. et al
Chest CT and Clinical Follow-up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China
Annals of the American Thoracic Society, July 2020; doi.org/10.1513/AnnalsATS.202004-324OC
Wilder-Smith A. et al.
Lancet Infect Dis., May 2020; doi: 10.1016/S1473-3099(20)30129-8
Sjödin H. et al.
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020.
Euro Surveill., April 2020; doi: 10.2807/1560-7917.ES.2020.25.13.2000280
Salzberger B. et al.
Infection, April 2020; doi: 10.1007/s15010-020-01409-4
CLINICAL FEATURES AND MORTALITY
Aziz M et al
The Association of “Loss of Smell” to COVID-19: A Systematic Review and Meta-Analysis
The American Journal of Medical Sciences, November 2020; doi.org/10.1016/j.amjms.2020.09.017
Rattka M et al
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis
Heart, December 2020; DOI: 10.1136/heartjnl-2020-318360
Ludwig M et al
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany
International Journal of Infectious Diseases, 3 December 2020; DOI: 10.1016/j.ijid.2020.11.204
Friedman J et al
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic
JAMA, 3 December 2020 ; doi:10.1001/jamapsychiatry.2020.4218
Sweeney TE et al
Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019
Critical Care Medicine, 17 November 2020; DOI: 10.1097/CCM.0000000000004786
Fancourt D et al
Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study
Sonnweber T et al
Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial
European Respiratory Journal , 10 December 2020 ; doi: 10.1183/13993003.03481-2020
Roedl K et al
Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany
Austrian Critical Care, 27 October 2020; doi.org/10.1016/j.aucc.2020.10.009
Manzano GS et al
Covid-19–associated myopathy caused by type I interferonopathy
NEJM, 20 November 2020; DOI: 10.1056/NEJMc2031085
Shappell CN et al
Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?
Critical Care Medicine, 24 August 2020; doi: 10.1097/CCM.0000000000004601
Hubiche T et al
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic
JAMA, 25 November 2020; doi:10.1001/jamadermatol.2020.4324
Xuejiao L et al
Three-month pulmonary function and radiological outcomes in COVID-19 survivors: a longitudinal patient cohort study
Chan PS et al
Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic
JAMA, 14 November 2020 ; doi:10.1001/jamacardio.2020.6210
Azzi Y et al
Covid-19 and solid organ transplantation: a review article
Transplantation, November 2020 ; DOI: 10.1097/TP.0000000000003523
Achar A et al
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance
Cells, October 2020 ; doi.org/10.3390/cells9112360
Martinez-Fierro M et al
The role of close contacts of COVID-19 patients in the SARS-CoV-2 transmission: an emphasis on the percentage of non-evaluated positivity in Mexico
American Journal of Infection Control, 07 October 2020; doi: 10.1016/j.ajic.2020.10.002
AlSamman M et al
Non-respiratory presentations of COVID-19, a clinical review.
American Journal of Emergency Medicine, 24 September 2020; doi: 10.1016/j.ajem.2020.09.054
Zhang W et al
Clinical characteristics and outcomes in elderly with coronavirus disease 2019 in Beijing, China: a retrospective cohort study
Internal and Emergency Medicine, 10 October 2020: doi.org/10.1007/s11739-020-02517-7
Jary A. et al.
Clinical presentation of Covid-19 in health care workers from a French University Hospital
Journal of Infection, September 2020; doi: 10.1016/j.jinf.2020.06.048
Carsana L. et al .
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
The Lancet, October 2020; doi.org/10.1016/ S1473-3099(20)30434-5
Salem N. et al.
Thromboelastography findings in critically ill COVID-19 patients
Journal of Thrombosis and Thrombolysis, October 2020; doi.org/10.1007/s11239-020-02300-7
Bilaloglu S et al
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
JAMA, August 2020; DOI: 10.1001/jama.2020.13372
Webb B.J. et al.
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
The Lancet; September 29, 2020DOI:https://doi.org/10.1016/S2665-9913(20)30343-X
Lv H. et al.
Prevalence and recovery time of olfactory and gustatory dysfunctions of hospitalized patients with COVID19 in Wuhan, China
International J Infectious Diseases, September 2020 ; doi.org/10.1016/j.ijid.2020.09.039
Bos L.D.J. et al.
Severe COVID-19 Infections—Knowledge Gained and Remaining Questions
Contou D. et al.
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
Ann Intensive Care, September 2020; doi: 10.1186/s13613-020-00736-x
Kilaru A.S. et al.
Return Hospital Admissions Among 1419 Covid‐19 Patients Discharged from Five US Emergency Departments
Academic Emergency Medicine, August 2020; doi.org/10.1111/acem.14117
Atalla E. et al.
Readmissions among Patients with COVID‐19
Int. J Clin. Practice, September 2020; doi.org/10.1111/ijcp.13700
Chen Q. et al.
Infection, August 2020; doi: 10.1007/s15010-020-01432-5
Harmouch F. et al
Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID‐19 patients
Journal of Medical Virology, July 2020; doi.org/10.1002/jmv.26347
Jeong I.K. et al
Diabetes and COVID-19: Global and Regional Perspectives
Diabetes Research and Clinical Practice, August 2020; doi.org/10.1016/j.diabres.2020.108303
Merkler A.E. et al
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza
JAMA Neurology, July 2020; doi:10.1001/jamaneurol.2020.2730
Shi D. et al
Clinical characteristics and factors associated with long term viral excretion in patients with SARS CoV 2 infection: a single center 28 day study
Journal of Infectious Diseases, July 2020; doi: 10.1093/infdis/jiaa388
Yang B.Y. et al
Clinical characteristics of patients with Coronavirus Disease 2019 (COVID-19) receiving emergency medical services in King County, Washington
JAMA Network Open, July 2020; doi:10.1001/jamanetworkopen.2020.14549
Liu Q. et al
Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia
Journal of Infection, July 2020; doi.org/10.1016/j.jin.2020.07.012
Bilaloglu S. et al
Thrombosis in hospitalized patients with COVID-19 in a New York City health system
JAMA, July 2020 ; doi: 10.1001/jama.2020.13372
Antinori S. et al.
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia
Le Infezioni in Medicina, Suppl. 1, 2020; 29-36
Samidoust P. et al.
Risk of hepatic failure in COVID-19 patients: A systematic review and meta-analysis
Le Infezioni in Medicina, Suppl. 1, 2020; 96-103
Ibanez-Samaniego L. et al
Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19
Journal of Infectious Diseases, June 2020; doi.org/10.1093/infdis/jiaa355
Jary A et al
Clinical presentation of Covid-19 in health care workers from a French University Hospital
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.048
Hughes S et al
Bacterial and fungal coinfection among hospitalised patients with COVID-19: A retrospective cohort study in a UK secondary care setting
Clinical Microbiology and Infection, June 2020; doi.org/10.1016/j.cmi.2020.06.025
Lehmann CJ et al
Community Acquired Co-infection in COVID-19: A Retrospective Observational Experience
Clinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa902
Abdel-Mannan O et al
Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children
JAMA Neurology, July 2020; doi:10.1001/jamaneurol.2020.2687
Bianchetti et al.,
Clinical presentation of COVID19 in dementia patients
J Nutr Health Aging, May 2020; doi: 10.1007/s12603-020-1389-1
Ma et al.,
COVID-19 and the Digestive System
Journal of Gastroenterology and Hepatology; March 2020; doi.org/10.1111/jgh.15047
Mercante G. et al.
Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
JAMA Otolaryngology–Head & Neck Surgery, June 2020; doi:10.1001/jamaoto.2020.1155
Hubiche et al.
Negative SARS-CoV-2 PCR in patients with chilblain-like lesions
Lancet Infectious Diseases, June 2020 ; doi.org/10.1016/ S1473-3099(20)30518-1
Minus P et al.
High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia
Clinical Microbiology and Infection, June 2020; doi: 10.1016/j.cmi.2020.06.011
Bravi F. et al.
Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens
PlosOne, June 2020; doi.org/10.1371/journal.pone.0235248
Herman A. et al.
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic
JAMA Dermatology, June 2020 ; doi:10.1001/jamadermatol.2020.2368
Matar R. et al.
Clinical presentation and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis
Clinical infectious Diseases, June 2020 ; doi.org/10.1093/cid/ciaa828
Tan T. et al.
Association between high serum total cortisol concentrations and mortality from COVID-19
Lancet Diabetes & Endocrinology, June 2020 ; doi.org/10.1016/ S2213-8587(20)30216-3
Grant M.C. et al.
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta- analysis of 148 studies from 9 countries
PlosOne, June 2020; doi.org/10.1371/journal.pone.0234765
Roca-Ginés et al.
Assessment of acute acral lesions in a case sSries of children and adolescents during the COVID-19 pandemic
JAMA Dermatology, June 2020; doi:10.1001/jamadermatol.2020.2340
Long Q.X. et al.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Nature Medicine, June 2020; doi.org/10.1038/s41591-020-0965-6
Clerkin K.J. et al.
Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046941
Vardeny O. et al.
Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046837
Interim guidance
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected World Health organization (WHO), March 2020
Wang X. et al.
Clin Microbiol Infect, April 2020; doi: 10.1016/j.cmi.2020.03.032
Rabaan A.A. et al.
Infez Med., June 2020; Ahead Of Print; 28 (2): 174-184
Gervasoni G. et al.
Clinical features and outcomes of HIV patients with coronavirus disease 2019
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa579
Li D. et al.
Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
JAMA, May 2020; doi:10.1001/jamanetworkopen.2020.8292
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
JAMA Intern Med. , May 2020; doi:10.1001/jamainternmed.2020.2033
Masetti C. et al.
High mortality in COVID‐19 patients with mild respiratory disease
European Journal of Clinical Investigation, April 2020; doi.org/10.1111/eci.13314
Giacobbe D.R. et al.
Bloodstream infections in critically ill patients with COVID‐19
European Journal of Clinical Investigation, June 2020; doi.org/10.1111/eci.13319
High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia
Clinical Microbiology and Infection, June 2020; doi: 10.1016/j.cmi.2020.06.011
Bravi F. et al.
Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens
PlosOne, June 2020; doi.org/10.1371/journal.pone.0235248
Herman A. et al.
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic
JAMA Dermatology, June 2020 ; doi:10.1001/jamadermatol.2020.2368
DIAGNOSTIC
Choe PG et al
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection
Emerging Infectious Diseases, December 2020; DOI: 10.3201/eid2703.204543
Pilarowski G et al
Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing
Clinical Infecitous Diseases, December 2020; doi.org/10.1093/cid/ciaa1890
Wanberg A et al
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Science, December 2020 ; DOI: 10.1126/science.abd7728
Yu F et al
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19
Annals of Internal Medicine, December 2020; doi.org/10.7326/M20-33
Hingrat Q et al
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
Clinical Microbiology and Infection, December 2020; doi.org/10.1016/j.cmi.2020.11.025
Agarwal V et al
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
Cell Death Discovery – Nature, December 2020; doi.org/10.1038/s41420-020-00375-y
Dugdale CM et al
Clinical, laboratory, and radiologic characteristics of patients with initial false-negative SARS-CoV-2 nucleic acid amplification test results
Open Forum Infectious Diseases, November 2020; doi.org/10.1093/ofid/ofaa559
Cervia C et al
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Journal of Allergy and Clinical Immunology, November 2020; doi.org/10.1016/j.jaci.2020.10.040
Wajnberg A et al
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Science, October 2020; DOI: 10.1126/science.abd7728
Murugesan K et al
Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response.
Clinical Infectious Diseases, 09 October 2020; doi.org/10.1093/cid/ciaa1537
Diao B et al
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection
Clinical Microbiology and Infection, 05 October 2020; DOI:doi.org/10.1016/j.cmi.2020.09.057
Seow J et al
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection
MedRxiv, July 2020 ; doi.org/10.1101/2020.07.09.20148429
Zhu J. et al.
Viral dynamics of SARS-CoV-2 in saliva from infected patients
Journal of Infection, September 2020; doi.org/10.1016/j.jinf.2020.06.059 0163-4453/
Shuren J. et al .
Covid-19 Molecular Diagnostic Testing — Lessons Learned
NEJM, September 2020 ;doi: 10.1056/NEJMp2023830
Salvatore P.P.et al.
Epidemiological Correlates of PCR Cycle Threshold Values in the Detection of SARS-CoV-2
Clinical Infectious Diseases, ciaa1469, 28 September 2020; doi.org/10.1093/cid/ciaa1469
Yokota I. et al.
Mass screening of asymptomatic persons for SARS-CoV-2 using saliva
Clinical Infectious Diseases August 2020; doi: 10.1093/cid/ciaa1388
Cozzi A. et al.
Chest x-ray in the COVID-19 pandemic: Radiologists' real-world reader performance
Eur J Radiol., September 2020; doi: 10.1016/j.ejrad.2020.109272
Poon K.S. et al.
Caveats of reporting cycles threshold from SARS-CoV-2 qualitative PCR assays: a molecular diagnostic laboratory perspective
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1399
Luo Y. R. et al.
Kinetics of SARS-CoV-2 antibody avidity maturation and association with disease severity
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1389
Ogata A.F. et al.
Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease
Clinical Chemistry, September 2020; doi.org/10.1093/clinchem/hvaa213
Jacobs J.L. et al.
Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean?
Clinical Infectious Diseases, September 2020; doi.org/10.1093/cid/ciaa1316
Watson J. et al.
Testing for SARS-CoV-2 antibodies
BMJ, September 2020; dx.doi.org/10.1136/bmj.m332
Sun J. et al.
Clin Microbiol Infect. September 2020; doi: 10.1016/j.cmi.2020.08.043
J Med Virol., July 2020; doi: 10.1002/jmv.26332
Ibarrondo F.J. et al
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
The New England Journal of Medicine, July 2020; doi: 10.1056/NEJMc2025179
Rijkers G. et al
Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
Journal of Infectious Diseases , June 2020; doi.org/10.1101/2020.06.09.20122036
Heald-Sargent T. et al
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)
JAMA Pediatrics, July 2020; doi:10.1001/jamapediatrics.2020.3651
Canziani L.M. et al
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Journal of Autoimmunity, July 2020; doi: 10.1016/j.jaut.2020.102511
Xu D. et al
Relationship Between serum SARS-CoV-2 nucleic acid (RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study
Clinical Infectious Diseases, July 2020; doi: 10.1093/cid/ciaa1085
Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater Houston, Texas, Area
JAMA Network Open, July 2020; doi:10.1001/jamanetworkopen.2020.16451
Karagiannidis C. et al
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Lancet Respiratory Medicine, July 2020; doi: https://doi.org/10.1016/S2213-2600(20)30316-7
Chatzidimitriou M. et al
Repeated negative serological testing in otherwise healthy patients with COVID-19
Journal of Infectious Diseases, July 2020; doi.org/10.1093/infdis/jiaa453
Percivalle E et al
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
Eurosurveillance, June 2020 ; doi.org/10.2807/1560-7917
Cento V. et al.
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.024
Hattori T. et al.
Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples
Journal of Infection, June 2020; doi.org/10.1101/2020.05.28.20115378
Zhao J et al.
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
Clinical Infectious Diseases, April 2020; doi:10.1093/cid/ciaa414
Xiang F. et al
Antibody detection and dynamic characteristics in patients with COVID-19
Clinical Infectious Diseases, April 2020; doi: 10.1093/cid/ciaa461
Developing antibody tests for SARS-CoV-2
Lancet,2020 April ; doi: 10.1016/S0140-6736(20)30788-1
To K.K. et al.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
Lancet Infect Dis., May 2020; Doi: 10.1016/S1473-3099(20)30196-1
Wölfel R. et al.
Virological assessment of hospitalized patients with COVID-2019.
Nature, April 2020; doi: 10.1038/s41586-020-2196-x
Xiao A.T. et al.
Clin Infect Dis., April 2020; doi: 10.1093/cid/ciaa460
Lan L. et al.
JAMA, February 2020 ; doi: 10.1001/jama.2020.2783
Li Y. Et al.
Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China.
J Med Virol, April 2020; doi: 10.1002/jmv.25905
Liang C. et al.
Positive RT-PCR test results after consecutively negative results in patients with COVID-19.
Infect Dis (Lond), April 2020 ; doi: 10.1080/23744235.2020.1755447
Ai T. et al.
Correlation of chest CT and RT-PCR testing in Coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases
Radiology, Feb. 2020; doi: 10.1148/radiol.2020200642
Chow E.J. et al.
JAMA, April 2020; doi: 10.1001/jama.2020.6637
Ozma M.A. et al.
Infez Med. June 2020, Ahead of print; 28 (2): 153-165
Interpreting Diagnostic Tests for SARS-CoV-2
JAMA, May 2020; doi:10.1001/jama.2020.8259
Lin A. et al.
Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa490
Jiuxin Qu et al.
Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Clin Infect Dis., April 2020 ; doi: 10.1093/cid/ciaa489
Long Q.X. et al.
Antibody responses to SARS-CoV-2 in patients with COVID-19
Nature Medicine, April 2020; doi.org/10.1038/s41591-020-0897-1
Sethuraman N. et al.
Interpreting Diagnostic Tests for SARS-CoV-2
JAMA, May 2020; doi:10.1001/jama.2020.8259
Wang X. et al.
Neutralizing Antibodies Responses to SARS CoV 2 in COVID-19 Inpatients and Convalescent Patients
MedRxiv, April 2020; doi.org/10.1101/2020.04.15.2006562
PROGNOSIS
Deng F et al
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19
Medicina Clinica, December 2020; doi.org/10.1016/j.medcli.2020.11.030
Legros V et al
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
Nature – Cellular and Molecular Immunology, September 2020; doi.org/10.1101/2020.08.27.20182493
McGurnaghan SJ et al
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
The Lancet, December 2020; doi.org/10.1016/S2213-8587(20)30405-8
Jorge A et al
Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
The Lancet, December 2020; doi.org/10.1016/S2665-9913(20)30422-7
Ramos – Rincon JM et al
Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain
The Journal of Gerontology, October 2020; DOI: 10.1093/gerona/glaa243
Di Micco P et al
Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
Journal of Clinical Medicine, December 2020; DOI: 10.3390/jcm9124134
Mmaximous S et al
Pragmatic Recommendations for the Management of COVID-19 Patients with Shock in Low- and Middle-Income Countries
American Journal of Tropical Medicine and Hygiene, December 2020; doi: 10.4269/ajtmh.20-1105
Shashikumar S et al
Development and Prospective Validation of a Deep Learning Algorithm for Predicting Need for Mechanical Ventilation
Chest, December 2020; doi.org/10.1016/j.chest.2020.12.009
Cordeanu EM et al
Prognostic Value of Troponin Elevation in COVID-19 Hospitalized Patients
Journal of Clinical Medicine, December 2020; doi: 10.3390/jcm9124078.
Cattelan AM et al
Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study
BMC Infectious Diseases, December 2020; doi.org/10.1186/s12879-020-05647-7
Goertz YMJ et al
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
ERJ Open Research, 10 September 2020; DOI: 10.1183/23120541.00542-2020
Yu Z et al
Clinical characteristics on admission predict in-hospital fatal outcome in patients aged >/=75 years with novel coronavirus disease (COVID-19): a retrospective cohort study
BMC Geriatrics, 30 November 2020; doi.org/10.1186/s12877-020-01921-0
Garrido P et al
Clinical value of procalcitonin in critically ill patients infected by SARS-CoV-2
The American Journal of Emergency Medicine, 07 November 2020; doi.org/10.1016/j.ajem.2020.11.011
Fattouch K et al
Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): A case-series report
The Journal of Thoracic and Cardiovascular Surgery, 22 October 2020; doi.org/10.1016/j.jtcvs.2020.09.138
Wu Z et al
A meta-analysis of the impact of COVID-19 on liver dysfunction
European Journal of Medical Research, November 2020; DOI: 10.1186/s40001-020-00454-x
Hoffman C et al
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada
Infection, October 2020 ; doi.org/10.1007/s15010-020-01538-w
Mueller AA et al
Inflammatory biomarker trends predict respiratory decline in COVID-19 patients
Cell, October 2020; doi.org/10.1016/j.xcrm.2020.100144
Fajnzylber J et al
SARS-CoV-2 viral load is associated with increased disease severity and mortality
JAMA, July 2020; doi: 10.1038/s41467-020-19057-5
Ibanez-Samaniego L. et al.
Elevation of liver fibrosis index FIB-4 is associated with poor clinical outcomes in patients with COVID-19
Journal of Infectious Diseases, September 2020; doi.org/10.1093/infdis/jiaa355
Altschul D. et al.
A novel severity score to predict inpatient mortality in COVID-19 patients
Nature Reviews, October 2020 ;doi.org/10.1038/s41598-020-73962-9
Alteri C et al
Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality
CID, 16 July 2020; doi.org/10.1093/cid/ciaa956
Yadaw A.S. et al.
Clinical features of COVID-19 mortality: development and validation of a clinical prediction model
The Lancet, September 2020; doi.org/10.1016/S2589-7500(20)30217X
Shoar S. et al.
Meta-analysis of cardiovascular events and related biomarkers comparing survivors versus non-survivors in patients with COVID-19
Am J Cardiol., September 2020; doi: 10.1016/j.amjcard.2020.08.044
Ko J.K. et al.
Risk factors for COVID-19-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system
Clinical Infectious Diseases, September 2020 ; doi.org/10.1101/2020.07.27.20161810
Meiler S. et al.
Can CT performed in the early disease phase predict outcome of patients with COVID 19 pneumonia? Analysis of a cohort of 64 patients from Germany
Eur J Radiol., August 2020; doi: 10.1016/j.ejrad.2020.109256
Ogata A.F. et al.
Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease
Clinical Chemistry, September 2020; doi.org/10.1093/clinchem/hvaa213
Li Q. et al.
Infection, August 2020; doi: 10.1007/s15010-020-01446-z
Alteri C. et al.
Clin Infect Dis., July 2020; doi: 10.1093/cid/ciaa956
Bartoletti M. et al
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study
Clinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa1065
Lee Dickens B.S. et al
Simple ‘Rule-of-6’ predicts severe COVID-19 disease
Clinical Infectious Diseases, July 2020;doi.org/10.1093/cid/ciaa938
Khalil A. et al
Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic
JAMA, July 2020; doi:10.1001/jama.2020.12746
Gupta S. et al
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
JAMA Internal Medicine, July 2020; doi: 10.1001/jamainternmed.2020.3596
Alteri C. et al
Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality
Clinical Infectious Diseases, July 2020;doi.org/10.1093/cid/ciaa956
Sing C.W. et al
Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors
Clinical Infectious Diseases, July 2020; doi.org/10.1093/cid/ciaa992
Ding T. et al
Potential influence of menstrual status and sex hormones on female sars-cov-2 infection: a cross-sectional study from multicentre in Wuhan, China
Clinical Infectious Diseases, July 2020; doi: 10.1093/cid/ciaa1022
Ruch Y. et al.
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients
Clinical Microbiology and Infection, July 2020; doi: 10.1016/j.cmi.2020.07.030
Feldstein LR et al
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
The New England Journal of Medicine, June 2020; doi: 10.1056/NEJMoa2021680
Trecarichi EM et al
Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility
MedRxiv.org, July 2020 ; doi.org/10.1101/2020.06.30.20143701
Cheng B et al
Predictors of progression from moderate to severe COVID-19: a retrospective cohort
Clinical Microbiology and Infection, July 2020; doi.org/10.1016/j.cmi.2020.06.033
Henry B.M. et al.
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Clin Chem Lab Med., April 2020; doi: 10.1515/cclm-2020-0369
Chen X. et al.
Clin Infect Dis. April 2020 ; doi: 10.1093/cid/ciaa449
Dong Ji et al.
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
Clinical Infectious Diseases, April 2020; Doi:10.1093/cid/ciaa344
Qu R. et al.
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
J Med Virol., March 2020; doi: 10.1002/jmv.25767
Yin S. et al.
J Thromb Thrombolysis, April 2020; doi: 10.1007/s11239-020-02105-8
Gao Y. et al.
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
J Med Virol., March 2020; doi: 10.1002/jmv.25770
Song C.Y. et al.
COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients
This article has not been peer-reviewed
Gasmi et al.
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Clinical Immunology, April 2020; doi: 10.1016/j.clim.2020
Lauc G, Sinclair D.
Aging (Albany NY), April 2020; 10.18632/aging.103052
Hu L. et al.
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa539
Wang K. et al.
Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa538
Chen X. et al.
Clin Infect Dis. April 2020 ; doi: 10.1093/cid/ciaa449
Qu R. et al.
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
J Med Virol., March 2020; doi: 10.1002/jmv.25767
Gao Y. et al.
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy
J. Clin. Med. May 2020; doi:10.3390/jcm9051548
Yan X et al
Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study
Journal of Medical Virology, May 2020; doi.org/10.1002/jmv.26061
Galloway J.B. et al.
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study
Journal of Infection, May 2020; doi.org/10.1016/j.jinf.2020.05.064
TREATMENT
Khullar R et al
Effects of Prone Ventilation on Oxygenation, Inflammation, and Lung Infiltrates in COVID-19 Related Acute Respiratory Distress Syndrome: A Retrospective Cohort Study
Journal of Clinical Medicine, 21 December 2020; doi.org/10.3390/jcm9124129
Rubin D et al
FDA Approval of Remdesivir — A Step in the Right Direction
NEJM, 31 December 2020; DOI: 10.1056/NEJMp2032369
Dauby N et al
Reply to the letter to the editor “Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality.”
International Journal of Antimicrobial Agents, 13 December 2020; doi: 10.1016/j.ijantimicag.2020.106261.
ACTIV-3/TICO LY-CoV555 Study Group
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
NEJM, 22 December 2020; DOI: 10.1056/NEJMoa2033130
Combination of Tocilizumab and steroids to improve mortality in patients with severe COVID-19 Infection: A Spanish, multicenter, cohort study
Infectious Diseases and Therapy, 6 December 2020; DOI: 10.1007/s40121-020-00373-8
Bramante CT et al
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
The Lancet, 3 December 2020 ; doi.org/10.1016/ S2666-7568(20)30033-7
Butt JH et al
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study
BMJ Open, 4 December 2020; doi: 10.1136/bmjopen-2020-044421
Kalil AC et al
Baricitinib plus Remdesivir for HospitalizedAdults with Covid-19
NEJM, 11 December 2020 ; DOI: 10.1056/NEJMoa2031994
Stone JH et al
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
NEJM, 10 December 2020 ; DOI: 10.1056/NEJMoa2028836
Abramowicz M et al
An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19
The Medical Letter on Drugs and Therapeutics –JAMA, 11 December 2020; doi:10.1001/jama.2020.24415
Moehring RW et al
Compiling Observational Research During a Pandemic: A Necessary Bridge
Clinical Infectious Diseases, 11December 2020; doi.org/10.1093/cid/ciaa1705
Simonovich VA et al
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
NEJM, 24 November 2020; DOI: 10.1056/NEJMoa2031304
Mitjià O et al
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
NEJM, 24 November 2020 ; DOI: 10.1056/NEJMoa2021801
Bronte V et al
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
The Journal of Clinical Investigation, 18 August 2020; doi.org/10.1172/JCI141772
Corominas H et al
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort
Clinical Immunology, 12 November 2020 ; doi.org/10.1016/j.clim.2020.108631
Cassone A et al
Chloroquine/hydroxycloroquine and COVID-19: need to know more about
Future Microbiology, 18 November 2020; doi.org/10.2217/fmb-2020-0247
Hueso T et al
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
Blood, 12 November 2020 ; doi: 10.1182/blood.2020008423
Wesley HS et al
Effect of Hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19 : a randomized clinical trial
JAMA, 9 November 2020 ; doi:10.1001/jama.2020.22240
Saag MS
Misguided use of Hydroxychloroquine for COVID-19: the infusion of politics into science
JAMA, 9 November 2020; DOI: 10.1001/jama.2020.22389
Taccone FS et al
Higher intensity thromboprophylaxis regimensand pulmonary embolism in critically Ill Coronavirus disease 2019 patiens
Critical Care Medicine, November 2020; doi: 10.1097/CCM.0000000000004548
Kim PS et al
Therapy for early COVID-19 a critical need
JAMA, 11 November 2020; doi:10.1001/jama.2020.22813
Mazhar F et al
Use of hydroxychloroquine and chloroquine in COVID-19: How good isthe quality of randomized controlled trials?
International Journal of Infectious Diseases, December 2020; doi.org/10.1016/j.ijid.2020.09.1470
Dubée V et al
A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
MedRXiv, October 2020; doi.org/10.1101/2020.10.19.20214940
Perrone F et al
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
Journal of Translational Medicine, October 2020; doi.org/10.1186/s12967-020-02573-9
Chen P et al
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
NEJM, October 2020 ; DOI: 10.1056/NEJMoa2029849
Gremese E et al
Sarilumab use in severe SARS-CoV-2 pneumonia
EClinical Medicine, May 2020; doi.org/10.1101/2020.05.14.20094144
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
JAMA, October 2020 ; DOI: 10.1001/jama.2020.16761
Simon NM et al
Mental Health Disorders Related to COVID-19–Related Deaths
JAMA, 12 October 20202 ; doi:10.1001/jama.2020.19632
Cantini F. et al.
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
Drugs, October 2020; doi.org/10.1007/s40265-020-01421-w
Stone J.H. et al.
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
New England J Medicine, October 2020; doi: 10.1056/NEJMoa2028836
Cingolani A et al
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
Infection. 2020 Jul 8 ;doi: 10.1007/s15010-020-01476-7
Yamamura H et al
Effect of favipiravir and an antiinflammatory strategy for COVID-19
Critical Care, July 2020; doi.org/10.1186/s13054-020-03137-5
Rogers R. et al.
Convalescent plasma for patients with severe COVID-19: a matched cohort study
Clinical Infectious Diseases, August 2020 ;doi.org/10.1101/2020.08.18.20177402
Ladapo J.A. et al.
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis
MedRXiv, September 2020; doi.org/10.1101/2020.09.30.20204693
Stevenson D.R. et al
Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19
Clinical Infectious Diseases, October 2020; doi.org/10.1093/cid/ciaa1559
Beigel J.H. et al
Remdesivir for the Treatment of Covid-19 — Final Report
New England JMedicine, October 2020; doi: 10.1056/NEJMoa2007764
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
Cao B. et al.
Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
The Lancet, October 2020; doi.org/10.1016/S0140-6736(20)32078-X
Chaijamorn W et al
Antiviral dosing modification for coronavirus disease 2019–infected patients receiving extracorporeal therapy
Critical Care Med, October 2020; doi: 10.1097/CCE.0000000000000242
Wilt TJ et al
Remdesivir for adults with covid-19: a living systematic review for an american college of physicians practice points
Annals of Internal Medicine, October 2020; doi: 10.7326/M20-5752
RECOVERY Collaborative Group
Effect of hydroxychloroquine in hospitalized patients with covid-19
New England JMedicine, October 2020; doi: 10.1056/NEJMoa2022926
Sing CW et al
Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors
CID, 15 july 2020; doi.org/10.1093/cid/ciaa992
Schultze A. et al.
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Open AccessPublished, September 24, 2020; doi.org/10.1016/S2213-2600(20)30415-X
.
Martinez-Sanz J. Et al.
Clinical Microbiology and Infection; June 2020; doi.org/10.1101/2020.06.08.20125245
Khai Li C. Et al.
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
Cochrane Systematic Review; 12 October 2020;
Juul S. et al.
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Vitte J. Et al.
Front Immunol., August 2020; doi: 10.3389/fimmu.2020.02159
Durante-Mangoni E. et al.
Early experience with remdesivir in SARS‑CoV‑2 pneumonia
Infection, September 2020 ; doi.org/10.1007/s15010-020-01448-x
McCaw Z.R. et al.
Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
Contemp. Clin Trials., September 2020; doi: 10.1016/j.cct.2020.106145
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Catteau L. et al.
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
Int Journal of Antimicrobial Agents, August 2020;
Olender S.A. et al
Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care
Clinical Infectious Diseases, July 2020; doi: 10.1093/cid/ciaa1041
Corral L. et al
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
MedRxiv.org, June 2020; doi.org/10.1101/2020.06.17.20133579
Oteo J.A. et al
A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications
MedRxiv.org, June 2020 ; doi.org/10.1101/2020.06.10.20101105
Oscanoa T.J. et al
A pharmacological perspective of Chloroquine in SARS-CoV-2 infection
International Journal of Antimicrobial Agents, July 2020;
Lemaitre F. et al
Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments
Fundamental and Clinical Pharmacology, July 2020;
Khandelwal R. et al.
Shape-based machine learning models for the potential novel COVID-19 protease inhibitors assisted by molecular dynamics simulation
Curr. Top. Med. Chem., July 2020; doi: 10.2174/1568026620666200704135327
Cheng F. et al.
COVID-19 Treatment: combining anti-Inflammatory and antiviral therapeutics using a Network-Based approach
doi.org/10.3949/ccjm.87a.ccc037
Samuel S et al
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with pcr positive sars-cov-2 infection including drug induced changes in the corrected qt interval (qtc)
Heart Rhythm, July 2020 ; doi: 10.1016/j.hrthm.2020.06.033
Bani-Sadr F. et al
Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study
International Journal Antimicrob. Agents, August 2020;
Rossotti R. et al
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: a comparative analysis
Journal of Infection, July 2020; doi.org/10.1016/j.jinf.2020.07.008
Liu A. et al
Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery
Clinical Microbiology and Infenction, July 2020; doi.org/10.1016/j.cmi.202.07.009
Cavalcanti A.B. et al
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
The New England Journal of Medicine, July 2020; doi: 10.1056/NEJMoa2019014
Di Perri G. et al.
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
Le Infezioni in Medicina, Suppl. 1, 2020; 52-56
Viale P.L. et al.
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin
Le Infezioni in Medicina, Suppl. 1, 2020; 118-121
Navarro-Millàn et al
Use of anakinra to prevent mechanical ventilation in severe COVID‐19: a case series
Arthritis & Rheumatology, June 2020; doi.org/10.1002/art.41422
Neupane K. et al.
Potential treatment options for COVID-19: a comprehensive review of global pharmacological development efforts
Cureus, June 2020 ; doi : 10.7759/cureus.8845
Ng KK et al
Acute respiratory failure secondary to COVID-19 viral Pneumonia managed with hydroxychloroquine/azithromycin treatment
Cureus, May 2020; doi:10.7759/cureus.8268
https://www.cureus.com/articles/32177-acute-respiratory-failure-secondary-to-covid-19-viral-pneumonia-managed-with-hydroxychloroquineazithromycin-treatment
Arshad S et al
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
International Journal of Infectious Diseases, July 2020; doi.org/10.1016/j.ijid.2020.06.099
Moanna A et al
Use of Baricitinib in Patients with Moderate and Severe COVID-19
Clinical Infectious Diseases, June 2020; doi.org/10.1093/cid/ciaa879
Montero-Baladia M. et al.
Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.006
Price C.C. et al.
Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes
Chest, June 2020 ; doi.org/10.1016/j.chest.2020.06.006
Jordan S.C. et al
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Clinical Infectious Diseases, June 2020; doi.org/10.1093/cid/ciaa812
Deftereos S.G. et al.
Effect of colchicine vs standard care on cardiac and Inflammatory biomarkers and clinical outcomes in patients hospitalized with Coronavirus disease 2019
JAMA, June 2020 ; doi:10.1001/jamanetworkopen.2020.13136
Guaraldi G. et al.
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Lancet Rheumatology, June 2020; doi.org/10.1016/S2665-9913(20)30173-9
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext
Cantini F. et al.
Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia
Journal of Infection, June 2020; doi: 10.1016/j.jinf.2020.06.052
Bhimraj A. et al
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Disponibile online at https://www.idsociety.org/COVID19guidelines
Grein J et al.
N Engl J Med., April 2020; doi: 10.1056/NEJMoa2007016
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.
Science & Society, 2020; doi.org/10.1016/j.tips.2020.03.006
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A Review.
JAMA, 2020; doi:10.1001/jama.2020.6019
Di Giambenedetto S. et al.
Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
J Med Virol., April 2020; doi: 10.1002/jmv.25897
COVID-19 guidelines
www.idsociety.org – Last update April 2020
Esposito S. et al.
Update on treatment of COVID-19: ongoing studies between promising and disappointing results.
Infez. Med., June 2020; 28 (2): 198-211. Ahead of print
Gasmi A. et al.
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Clin Immunol., April 2020; doi: 10.1016/j.clim.2020.108409
Caly L. Et al.
The FDA-approved drug invermectin inhibits the replication of SARS-CoV-2 in vitro
Antiviral Res., April 2020; doi: 10.1016/j.antiviral.2020.104787
Lane J.C.E et al.
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
MedRxiv, 2020; doi.org/10.1101/2020.04.08.20054551
Huang M. et al.
Treating COVID-19 with Chloroquine
Journal of Molecular Cell Biology, 2020; doi.org/10.1093/jmcb/mjaa014
Luo P. et al.
Tocilizumab treatment in COVID-19: A single center experience.
J Med Virol., April 2020; doi: 10.1002/jmv.25801
Wu J. Et al.
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).
J Intern Med., March 2020; doi: 10.1111/joim.13063
Kalil A. C., et al.
Treating COVID-19. Off-label drug use, compassionate use and randomized clinical trials during pandemics.
JAMA, March 2020; doi: 10.1001/jama.2020.4742
Savarino A. et al.
Effects of choloroquine on viral infections: an old drug against today’s diseases.
The Lancet, November 2003; vol 3
Cao B. et al.
A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19.
N Eng. J. Med, March 2020; doi: 10.1056/NEJMoa2001282
Gautret P. et al.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents., March 2020; doi: 10.1016/j.ijantimicag.2020.105949
Sheahan T.P. et al.
Nat Commun., January 2020; doi: 10.1038/s41467-019-13940-6
Song R. et al.
Infection., April 2020; doi: 10.1007/s15010-019-01364-9
Letter to the Editor
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Cell. Research, February 2020; doi.org/10.1038/s41422-020-0282-0
Dong L. et al.
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Drug Discov Ther., 2020; doi: 10.5582/ddt.2020.01012
Zhang W. et al.
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Clin Immunol., May 2020; doi: 10.1016/j.clim.2020.108393
Agenzia Italiana del Farmaco
Sperimentazioni cliniche – COVID-19
Tawfiq A.l. et al.
Travel Med Infect Dis. March 2020; doi: 10.1016/j.tmaid.2020.101615
Xu X. et al.
Effective treatment of severe COVID-19 patients with tocilizumab.
Proc. Natl. Acad. Sci. USA, April 2020; . 2020 Apr 29; doi: 10.1073/pnas.2005615117
Rajendran K. et al.
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
Journal of Medical Virology, May 2020; doi.org/10.1002/jmv.25961
Goldman J. et al.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
NEJM, May 2020 ; doi: 10.1056/NEJMoa2015301
Wang Y.
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
The Lancet, May 2020; doi.org//10.1016/S0140-6736(20)31022-9
Li L. et al.
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
JAMA, June 2020; doi:10.1001/jama.2020.10044
Guérin V. et al.
Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19
Preprints, May 2020; doi: 10.20944/preprints202005.0486.v1
RECOVERY study group
Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial
COVID-19/HIV-AIDS
Lombardi F et al
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy
Clinical Microbiology and Infection, December 2020; DOI: 10.1016/j.cmi.2020.11.026
Bhaskaran K et al
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
The Lancet, December 2020; doi.org/10.1016/S2352-3018(20)30305-2
Collins LF et al
Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA
AIDS, October 2020; DOI: 10.1097/QAD.0000000000002632
Cooper T.J. et al.
HIV Med, July 2020; doi: 10.1111/hiv.12911.
Chazot R. et al.
J Infect Dis., July 2020 ; doi: 10.1093/infdis/jiaa433
AIDS, July 2020; doi: 10.1097/QAD.0000000000002632
Charre C. et al
COVID-19 attack rate in HIV-infected patients and in PrEP users
AIDS, July 2020; doi: 10.1097/QAD.0000000000002639
Ho H et al
Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV
Journal of Infectious Diseases, June 2020; doi.org/10.1093/infdis/jiaa
Del Amo J. et al.
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
Annals of Internal Medicine, June 2020; doi.org/10.7326/M20-3689
Childs K. et al.
Hospitalized patients with COVID-19 and HIV: a case series
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa657
Vizcarra P. et al.
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
The Lancet HIV, May 2020; doi.org/10.1016/S2352-3018(20)30164-8
Shalve N. et al.
Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19
Clinical Infectious Diseases, May 2020; doi.org/10.1093/cid/ciaa635
VACCINES
Baden LR et al
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
NEJM, 30 December 2020; DOI: 10.1056/NEJMoa2035389
Maintaining Safety with SARS-CoV-2 Vaccines
NEJM, 30 December 2020; DOI: 10.1056/NEJMra2035343
Szilagyi PG et al
National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020
JAMA, 29 December 2020; doi:10.1001/jama.2020.26419
Gostin LO et al
Mandating COVID-19 Vaccines
JAMA, 29 December 2020; doi:10.1001/jama.2020.26553
Palacios CP et al
Vaccinating Detained Migrants against SARS-CoV-2 — Preventing Another Tragedy
NEJM, 30 December 2020; DOI: 10.1056/NEJMpv2035416
Olivier SE et al
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
Morbidity and Mortality Weekly Report, 20 December 2020; doi.org/10.15585/mmwr.mm695152e1
Lianpan D et al
Viral targets for vaccines against COVID-19
Nature, 18 December 2020; doi.org/10.1038/s41577-020-00480-0
Ball P
The lightning-fast quest for COVID vaccines — and what it means for other diseases
Nature, 18 December 2020; doi.org/10.1038/d41586-020-03626-1
Pollard AJ et al
A guide to vaccinology: from basic principles to new developments
Nature reviews, 22 December 2020; doi.org/10.1038/s41577-020-00479-7
Voysey M et al
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
The Lancet, 8 December 2020; DOI:doi.org/10.1016/S0140-6736(20)32661-1
Knoll M et al
Oxford–AstraZeneca COVID-19 vaccine efficacy
The Lancet, 8 December 2020; doi.org/10.1016/S0140-6736(20)32623-4
The Centers fo Disease Control and Prevention
Understanding and Explaining mRNA COVID-19 Vaccines
Pardi N et al
mRNA vaccines — a new era in vaccinology
Nature,12 January 2018 ; doi.org/10.1038/nrd.2017.243
Polack FP et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
NEJM, 10 December 2020; DOI: 10.1056/NEJMoa2034577
FDA Briefing Document
Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020
WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation
Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them
NEJM, 2 December 2020; DOI: 10.1056/NEJMp2033538
Paul Offitt
Coronavirus Vaccine Update with Paul Offitt
JAMA Network – Youtube
https://www.youtube.com/watch?v=V4xClOYM3iE&utm_source=silverchair&utm_campaign=jama_network&utm_content=covid_weekly_highlights&cmp=1&utm_medium=email
December 2, 2020.
The Lancet Editorial Board
COVID-19 vaccines: no time for complacency
The Lancet, 21 November 2020; DOI: 10.1016/S0140-6736(20)32472-7
Reche PA et al
Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and Vaccines
Frontiers in Immunology, 16 October 2020 ; doi: 10.3389/fimmu.2020.586984
Callaway E
COVID vaccine excitement builds as Moderna reports third positive result
Nature Communications, 16 November 2020; doi.org/10.1038/d41586-020-03248-7
Halstead SB et al
COVID-19 Vaccines: Should We Fear ADE?
The Journal of Infectious Diseases, 12August 2020; doi.org/10.1093/infdis/jiaa518
Uzcategui EM
What Pfizer's landmark COVID vaccine results mean for the pandemic
Nature, 9 November 2020; doi.org/10.1038/d41586-020-03166-8
Sharma O et al
A review of the progress and challenges of developing a vaccine for COVID-19
Front. Immunol, 14 October 2020; doi.org/10.3389/fimmu.2020.585354
Lerner AM et al
Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
JAMA, October 2020 ; doi:10.1001/jama.2020.21946
Xia S et al
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
The Lancet, 15 October 2020; doi.org/10.1016/S1473-3099(20)30831-8
Quiang G. et al.
Development of an inactivated vaccine candidate for SARS-CoV-2
Science, July 2020; doi: 10.1126/science.abc1932
Jackson LA et al
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
The New England Journal of Medicine, July 14 2020 ;DOI: 10.1056/NEJMoa2022483
COVID versus NON COVID
Tralongo A. et al.
Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword?
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
Le Infezioni in Medicina, September 2020; vol. 28 n. 3
CO-INFECTION - SUPER INFECTION
Verweij PE et al
Fungal infections should be part of the core outcome set for COVID-19
The Lancet, 7 December 2020 ; doi.org/10.1016/S1473-3099(20)30591-0
Garde-Noguera J et al
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population
Cancers (Basel), 25 November 2020; doi.org/10.3390/cancers12123513
Riou M et al
Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study
Respiratory Medical Research, 12 November 2020; DOI: 10.1016/j.resmer.2020.100801
Burrel S et al
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19
International Journal of Infectious Diseases, October 2020; doi.org/10.1016/j.ijid.2020.10.040
Hughes S. et al.
Bacterial and fungal coinfection among hospitalised patients with COVID-19: A
Clinical Microbiology and Infection, October 2020; doi: 10.1016/j.cmi.2020.06.025
retrospective cohort study in a UK secondary care setting
Bartoletti M et al
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study
CID, 2020 Jul 28. doi: 10.1093/cid/ciaa1065
PEDIATRICS AND PREGNANCY
Chiu T et al
Changes in pediatric seizure-related emergency department attendances during COVID-19 - A territory-wide observational study
Journal of Formosan Medical Association, 21 November 2020; DOI: 10.1016/j.jfma.2020.11.006
Toubiana J et al
Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020
Eurosurveillance
Biasucci G et al
Safe perinatal management of neonates born to SARS-CoV-2 positive mothers at the epicenter of the Italian epidemic
Frontiers in Pediatrics, 29 October 2020; doi.org/10.3389/fped.2020.565522
Buonsenso D et al
A pediatric strategy for the next phase of the SARS-CoV-2 pandemic
Frontiers in Pediatrics, 9 October 2020; doi.org/10.3389/fped.2020.582798
Boushra M et al
COVID-19 in pregnancy and the puerperium: a review for emergency physicians
American Journal of Emergency Medicine, 2 November 2020; doi.org/10.1016/j.ajem.2020.10.055
Hernandez-Gaduno E
Comorbidities that predict acute respiratory syndrome coronavirus 2 test positivity in Mexican Children: A case-control study
PediatricObesity, 11 October 2020; doi.org/10.1111/ijpo.12740
Gunes H et al
What chances do children have against COVID-19? Is the answer hidden within the thymus?
European Journal of Pediatrics, 13 October 2020 ; doi.org/10.1007/s00431-020-03841-y
Feldstein L.R. et al.
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
The New England Journal of Medicine, June 2020; doi: 10.1056/NEJMoa2021680
Moraleda C et al
Multi-Inflammatory Syndrome in children related to SARS-CoV-2 in Spain
CID, 25 July 2020 ; DOI: 10.1093/cid/ciaa1042
LONG COVID SINDROME
Hampshire A et al
Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study
MedRXiv, October 2020; doi.org/10.1101/2020.10.20.20215863
IMPACT OF COVID ON "OTHER DISEASES"
Katsouras C et al
Greater decline of acute stroke admissions compared with acute coronary syndromes during COVID-19 outbreak in Greece: Cerebro/Cardiovascular implications amidst a second wave surge
European Journal of Neurology, 8 December 2020 ; DOI: 10.1111/ene.14666
